|
1
|
Chiang EP, Tsai SY, Kuo YH, et al: Caffeic
Acid Derivatives Inhibit the Growth of Colon Cancer: Involvement of
the PI3-K/Akt and AMPK Signaling Pathways. PloS One. 9:e996312014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boncheva V, Bonney SA, Brooks SE, et al:
New targets for the immunotherapy of colon cancer- does reactive
disease hold the answer? Cancer Gene Ther. 20. pp. 157–168. 2013,
View Article : Google Scholar
|
|
3
|
Carethers JM, Murali B, Yang B, et al:
Influence of Race on Microsatellite Instability and CD8+ T Cell
Infiltration in Colon Cancer. PloS One. 9:e1004612014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Selcukbiricik F, Bilici A, Tural D,
Erdamar S, Soyluk O, Buyukunal E, Demirelli F and Serdengecti S:
Are high initial CEA and CA 19-9 levels associated with the
presence of K-ras mutation in patients with metastatic colorectal
cancer? Tumour Biol. 34:2233–2239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mayer RJ, Garnick MB, Steele GD Jr and
Zamcheck N: Carcinoembryonic antigen (CEA) as a monitor of
chemotherapy in disseminated colorectal cancer. Cancer.
42:1428–1433. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Petrioli R, Licchetta A, Roviello G, et
al: CEA and CA19.9 as early predictors of progression in
advanced/metastatic colorectal cancer patients receiving
oxaliplatin- based chemotherapy and bevacizumab. Cancer Invest.
30:65–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Van den Eynden GG, Majeed AW, Illemann M,
et al: The multifaceted role of the microenvironment in liver
metastasis: biology and clinical implications. Cancer Res.
73:2031–2043. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fong D, Spizzo G, Gostner JM, et al:
TROP2: a novel prognostic marker in squamous cell carcinoma of the
oral cavity. Modern Pathol. 21:186–191. 2008.
|
|
9
|
Pak MG, Shin DH, Lee CH and Lee MK:
Significance of EpCAM and TROP2 expression in non-small cell lung
cancer. World J Surg Oncol. 10:532012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fong D, Moser P, Krammel C, et al: High
expression of TROP2 correlates with poor prognosis in pancreatic
cancer. Br J Cancer. 99:1290–1295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mühlmann G, Spizzo G, Gostner J, et al:
TROP2 expression as prognostic marker for gastric carcinoma. J Clin
Pathol. 62:152–158. 2009. View Article : Google Scholar
|
|
12
|
Zhang L, Zhou W, Velculescu VE, et al:
Gene expression profiles in normal and cancer cells. Science.
276:1268–1272. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fornaro M, Dell'Arciprete R, Stella M, et
al: Cloning of the gene encoding Trop- 2, a cell- surface
glycoprotein expressed by human carcinomas. Int J Cancer.
62:610–618. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
El Sewedy T, Fornaro M and Alberti S:
Cloning of the murine TROP2 gene: conservation of a PIP2- binding
sequence in the cytoplasmic domain of TROP- 2. Int J Cancer.
75:324–330. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Coldren CD, Helfrich BA, Witta SE, et al:
Baseline gene expression predicts sensitivity to gefitinib in non-
small cell lung cancer cell lines. Mol Cancer Res. 4:521–528. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bignotti E, Todeschini P, Calza S, et al:
Trop- 2 overexpression as an independent marker for poor overall
survival in ovarian carcinoma patients. Eur J Cancer. 46:944–953.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ambrogi F, Fornili M, Boracchi P, et al:
Trop-2 is a determinant of breast cancer survival. PloS One.
9:e969932014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cubas R, Li M, Chen C and Yao Q: Trop2: a
possible therapeutic target for late stage epithelial carcinomas.
Biochim Biophys Acta. 1796:309–314. 2009.PubMed/NCBI
|
|
19
|
Varughese J, Cocco E, Bellone S, et al:
Uterine serous papillary carcinomas overexpress human trophoblast-
cell- surface marker (Trop- 2) and are highly sensitive to
immunotherapy with hRS7, a humanized anti- Trop- 2 monoclonal
antibody. Cancer. 117:3163–3172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ripani E, Sacchetti A, Corda D and Alberti
S: Human Trop- 2 is a tumor- associated calcium signal transducer.
IntJ Cancer. 76:671–676. 1998. View Article : Google Scholar
|
|
21
|
Trerotola M, Li J, Alberti S and Languino
LR: Trop- 2 inhibits prostate cancer cell adhesion to fibronectin
through the beta1 integrin- RACK1 axis. J Cell Physiol.
227:3670–3677. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Trerotola M, Cantanelli P, Guerra E, et
al: Upregulation of Trop- 2 quantitatively stimulates human cancer
growth. Oncogene. 32:222–233. 2013. View Article : Google Scholar
|
|
23
|
Huang HY: Role of TROP2 in cancer and as
potential therapeutic target. Zhonghua Bing Li Xue Za Zhi.
42:860–863. 2013.Article in Chinese.
|
|
24
|
Lu J, Izvolsky KI, Qian J and Cardoso WV:
Identification of FGF10 targets in the embryonic lung epithelium
during bud morphogenesis. J Biol Chem. 280:4834–4841. 2005.
View Article : Google Scholar
|
|
25
|
Stoyanova T, Goldstein AS, Cai H, Drake
JM, Huang J and Witte ON: Regulated proteolysis of Trop2 drives
epithelial hyperplasia and stem cell self- renewal via beta-
catenin signaling. Genes Dev. 26:2271–2285. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Goldstein AS, Lawson DA, Cheng D, Sun W,
Garraway IP and Witte ON: Trop2 identifies a subpopulation of
murine and human prostate basal cells with stem cell
characteristics. Proc the Natl Acad Sci USA. 105:20882–20887. 2008.
View Article : Google Scholar
|
|
27
|
Antonic V, Stojadinovic A, Kester KE,
Weina PJ, Brücher BL, Protic M, Avital I and Izadjoo M:
Significance of infectious agents in colorectal cancer development.
J Cancer. 4:227–240. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Messick CA, Church J, Casey G and Kalady
MF: Identification of the methylator (serrated) colorectal cancer
phenotype through precursor serrated polyps. Dis Colon Rectum.
52:1535–1541. 2009. View Article : Google Scholar : PubMed/NCBI
|
